Analyst Ratings for Arcus Biosciences (RCUS)
RCUS Rating Summary
RCUS Price Target Summary
- Highest: $47.00 (Leerink)
- Lowest: $23.00 (Morgan Stanley)
- Average: $36.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$36.11 (+26.8%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$36.11 (+26.8%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/18/2026 | Truist Securities » Updated 9/8/2026 |
Supawat Thongthip | New Coverage | Buy (N/A) |
40.00 (35.00) |
23.78 (28.49) |
19.81% | Details |
| 2/12/2026 | Wells Fargo » Updated 8/6/2026 |
Jason Hass | Downgrade | Equal Weight (Overweight) |
26.00 (23.00) |
21.36 (28.49) |
33.38% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
